Formation Metals Announces Upsize to Previously Announced LIFE Offering and Private Placement of Units to $8.6 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESHighlights:Formation has planned a 20,000 metre total multi-phase drill program at its flagship N2 Gold ...
Santé log

LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”

Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble (protofibril ...
Game Rant

Starsand Island Hands-On Preview: Cozy by Design, Some Assembly Required

Game Rant goes hands-on with Seed Lab’s Starsand Island, exploring its professions, progression, and the rhythm of life it ...

First patient treated with Leqembi® (lecanemab) in the Nordics

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that Leqembi has now been made available at a private clinic in Finland and that the first patient has started treatment. BioArctic ...